Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | PRKCA | P17252 | 1/20 | 0.47 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.47 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.47 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.47 |
| ▸ | PAM | P19021 | 2/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30104654 | 0.98 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PRKCA | |
| SCHEMBL465547 | 0.98 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PRKCA | |
| SCHEMBL19821495 | 0.98 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PRKCA | |
| SCHEMBL465544 | 0.98 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PRKCA | |
| SCHEMBL18206768 | 0.98 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PRKCA | |
| SCHEMBL465548 | 0.98 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PRKCA | |
| SCHEMBL454068 | 0.98 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PRKCA | |
| SCHEMBL19821494 | 0.98 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PRKCA | |
| SCHEMBL19931336 | 0.98 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PRKCA | |
| SCHEMBL30104686 | 0.98 | LMNA (0.61) | LMNAALDH1A1MAPTMAPK1PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 346 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021098950-A1 | HOME CARE PRODUCT OR FORMULATION | SYMRISE AG (DE) | 2021-05-27 | — | — | WO | claimed |
| EP-1216036-B1 | TRANSDERMAL ADMINISTRATION OF N-(2,5-DISUBSTITUTED PHENYL)-N'-(3-SUBSTITUTED PHENYL)-N'-METHYL GUANIDINES | ALZA CORP (US) | 2005-11-16 | — | — | EP | claimed |
| EP-0934078-B1 | PERMEATION ENHANCERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS, DEVICES, AND METHODS | ALZA CORP (US) | 2002-12-18 | — | — | EP | claimed |
| EP-0828516-B1 | SKIN PERMEATION ENHANCER COMPOSITIONS USING ACYL LACTYLATES | ALZA CORP (US) | 2002-03-27 | — | — | EP | claimed |
| EP-0976391-A1 | Cosmetic and dermatological W/O emulsions, containing ionic and/or amphoteric detergents and the presence of an amount of silicone-emulgators | Beiersdorf Aktiengesellschaft (DE) | 2000-02-02 | — | — | EP | claimed |
| US-20240239730-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2024-07-18 | — | — | US | disclosed |
| EP-4389765-A2 | METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER | University of Southern California (US) | 2024-06-26 | — | — | EP | disclosed |
| US-11970436-B2 | Pharmaceutical compositions comprising monoterpenes | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2024-04-30 | — | — | US | disclosed |
| EP-4041412-B1 | CLEANSING PREPARATION CONTAINING CAESALPINIA SPINOSA GUM | BEIERSDORF AG (DE) | 2024-04-24 | — | — | EP | disclosed |
| EP-3749291-B1 | METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER | UNIV SOUTHERN CALIFORNIA (US) | 2024-01-03 | — | — | EP | disclosed |
| US-20230405125-A1 | TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL | Neonc Technologies, Inc. | 2023-12-21 | — | — | US | disclosed |
| EP-4279058-A1 | PREPARATION OF A COSMETIC CLEANSING COMPOSITION | Beiersdorf AG (DE) | 2023-11-22 | — | — | EP | disclosed |
| EP-0976391-A1 | Cosmetic and dermatological W/O emulsions, containing ionic and/or amphoteric detergents and the presence of an amount of silicone-emulgators | Beiersdorf Aktiengesellschaft (DE) | 2000-02-02 | — | — | EP | disclosed |
| EP-0943313-A2 | Hair cosmetics containing sunflower wax and possibly jojoba wax | Beiersdorf Aktiengesellschaft (DE) | 1999-09-22 | — | — | EP | disclosed |
| WO-1999045055-A1 | SULFONATED COMB POLYMERS AND PREPARATIONS, ESPECIALLY HAIR COSMETIC PREPARATIONS BASED ON SUCH SULFONATED COMB POLYMERS | BEIERSDORF AG (DE) | 1999-09-10 | — | — | WO | disclosed |
| EP-0937454-A2 | Cosmetic or dermatological compositions containing polysaccharides for the protection of sensitive skin against irritations | Beiersdorf Aktiengesellschaft (DE) | 1999-08-25 | — | — | EP | disclosed |
| EP-0562263-B2 | Hair washing composition | GOLDWELL GMBH (DE) | 1999-02-03 | — | — | EP | disclosed |
| EP-0535429-B1 | Hair spray composition | GOLDWELL AG (DE) | 1994-12-14 | — | — | EP | disclosed |
| EP-0562263-A1 | Hair washing composition | GOLDWELL GmbH (DE) | 1993-09-29 | — | — | EP | disclosed |
| EP-0535429-A2 | Hair spray composition | GOLDWELL AKTIENGESELLSCHAFT (DE) | 1993-04-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239730-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | SQLE, DHPS, GGPS1 | LMNA 907/4885ALDH1A1 793/4885MAPT 1232/4885 |
| US-11970436-B2 | Pharmaceutical compositions comprising monoterpenes | SQLE, DHPS, GGPS1 | LMNA 907/4885ALDH1A1 793/4885MAPT 1232/4885 |
| US-20230405125-A1 | TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL | IDH3A, IDH1, IDH3B | LMNA 2055/4885ALDH1A1 162/4885MAPT 4280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.